This elevation may suggest that the body is attempting to counteract anorexia, which is often seen in cancer patients—an endocrine response to the ‘ghrelin resistance’ observed in cancer patients—or a reaction to the muscle breakdown associated with cancer [3,59,60]. Here, GHRL is linked to cancer.